Lu L, Wang Y, Ye J, Han Y, et al. Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trial. Helicobacter 2022 Dec 1:e12940. doi: 10.1111/hel.12940.
PMID: 36458325